Plasma proteomic signatures of preclinical Alzheimer's disease in clinically unimpaired older adults.

Saved in:
Bibliographic Details
Title: Plasma proteomic signatures of preclinical Alzheimer's disease in clinically unimpaired older adults.
Authors: Trelle AN; Department of Neurology & Neurological Sciences, Stanford University School of Medicine, Stanford, CA, 94305, USA. atrelle@stanford.edu., Cody KA; Department of Neurology & Neurological Sciences, Stanford University School of Medicine, Stanford, CA, 94305, USA., Nguyen TT; Institute for Immunity, Transplantation, and Infection Operations, Stanford University School of Medicine, Stanford, CA, 94305, USA., Winer JR; Department of Neurology & Neurological Sciences, Stanford University School of Medicine, Stanford, CA, 94305, USA., Weiss S; Department of Neurology & Neurological Sciences, Stanford University School of Medicine, Stanford, CA, 94305, USA., Sai I; Department of Neurology & Neurological Sciences, Stanford University School of Medicine, Stanford, CA, 94305, USA., Ward T; Department of Psychology, Stanford University, Stanford, CA, 94305, USA., Cheng G; Department of Psychology, Stanford University, Stanford, CA, 94305, USA., Channappa D; Department of Neurology & Neurological Sciences, Stanford University School of Medicine, Stanford, CA, 94305, USA., Mendiola J; Department of Neurology & Neurological Sciences, Stanford University School of Medicine, Stanford, CA, 94305, USA., Al-Rajhi A; Department of Neurology & Neurological Sciences, Stanford University School of Medicine, Stanford, CA, 94305, USA., Raghuraman K; Department of Neurology & Neurological Sciences, Stanford University School of Medicine, Stanford, CA, 94305, USA., Sha SJ; Department of Neurology & Neurological Sciences, Stanford University School of Medicine, Stanford, CA, 94305, USA., Wilson EN; Department of Neurology & Neurological Sciences, Stanford University School of Medicine, Stanford, CA, 94305, USA.; Wu Tsai Neurosciences Institute, Stanford University, Stanford, CA, 94305, USA.; Phil and Penny Knight Initiative for Brain Resilience, Stanford University, Stanford, CA, 94305, USA., Wyss-Coray T; Department of Neurology & Neurological Sciences, Stanford University School of Medicine, Stanford, CA, 94305, USA.; Wu Tsai Neurosciences Institute, Stanford University, Stanford, CA, 94305, USA.; Phil and Penny Knight Initiative for Brain Resilience, Stanford University, Stanford, CA, 94305, USA., Maecker HT; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, 94305, USA., Wagner AD; Department of Psychology, Stanford University, Stanford, CA, 94305, USA.; Wu Tsai Neurosciences Institute, Stanford University, Stanford, CA, 94305, USA., Mormino EC; Department of Neurology & Neurological Sciences, Stanford University School of Medicine, Stanford, CA, 94305, USA.; Wu Tsai Neurosciences Institute, Stanford University, Stanford, CA, 94305, USA.; Molecular Imaging Program at Stanford (MIPS), Stanford University, Stanford, CA, 94305, USA.
Source: Molecular neurodegeneration [Mol Neurodegener] 2026 Apr 24; Vol. 21 (1). Date of Electronic Publication: 2026 Apr 24.
Publication Type: Journal Article
Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101266600 Publication Model: Electronic Cited Medium: Internet ISSN: 1750-1326 (Electronic) Linking ISSN: 17501326 NLM ISO Abbreviation: Mol Neurodegener Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1750-1326
DOI:10.1186/s13024-026-00941-5